Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Hackensack NJ, Paramus NJ, New Brunswick NJ, Easton PA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
for
Advanced Melanoma
Location: Hackensack NJ, Lake Success NY, Philadelphia PA,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT06112314
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
TVMR With the INNOVALVE System Trial - Early Feasibility Study
for
Mitral Valve Regurgitation (Degenerative or Functional)
Location: Manhasset NY, Morristown NJ, Philadelphia PA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 18+
Code: NCT04919980
Recruiting
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
Location: Hackensack NJ, Boston MA, Buffalo NY, Pittsburgh PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT06469281
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Upper Extremity Training for Chronic Cervical Spinal Cord Injury
for
Spinal Cord Injuries
Location: West Orange NJ
Sponsor: Kessler Foundation
Sex: All
Age: 18+
Code: NCT04921592
Recruiting
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
for
Relapsed Classic Hodgkin Lymphoma
Location: Hackensack NJ, Boston MA, Chicago IL, Nashville TN,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT04561206
Phase 2, Recruiting
Phase IB/II of CPX-351 for Relapse Prevention in AML
for
Acute Myeloid Leukemia (AML) in Remission
Location: Hackensack NJ, Philadelphia PA, Washington D.C. DC
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT04990102
Phase 1, Phase 2, Recruiting
TR(ACE) Assay Clinical Specimen Study
for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: Flemington NJ, East Setauket NY, Toms River NJ,
Sponsor: Biological Dynamics
Sex: All
Age: 21+
Code: NCT02934360
Recruiting
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Location: New Brunswick NJ, Boston MA, Chicago IL, Austin TX
Sponsor: Cellectis S.A.
Sex: All
Age: 18 - 70+
Code: NCT05607420
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
for
Thymoma, Thymic Carcinoma
Location: Hackensack NJ, Washington D.C. DC, Chicago IL,
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT06248515
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Hackensack NJ, Boston MA, Buffalo NY, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase 1, Phase 2, Recruiting
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
for
Solid Tumors
Location: Hackensack NJ, New Haven CT, Los Angeles CA
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT05471856
Phase 1, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Brunswick NJ, New Haven CT, Philadelphia PA,